Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
21.57
+0.01 (0.05%)
At close: Jan 30, 2026, 4:00 PM EST
21.55
-0.02 (-0.09%)
After-hours: Jan 30, 2026, 4:10 PM EST
Avadel Pharmaceuticals Market Cap
Avadel Pharmaceuticals has a market cap or net worth of $2.12 billion as of January 30, 2026. Its market cap has increased by 169.00% in one year.
Market Cap
2.12B
Enterprise Value
2.06B
1-Year Change
169.00%
Ranking
Category
Stock Price
$21.57
Market Cap Chart
Since April 15, 2024, Avadel Pharmaceuticals's market cap has increased from $1.54B to $2.12B, an increase of 37.37%. That is a compound annual growth rate of 19.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 2.12B | - |
| Dec 31, 2025 | 2.12B | 108.86% |
| Dec 31, 2024 | 1.01B | -34.23% |
| Apr 15, 2024 | 1.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Supernus Pharmaceuticals | 2.82B |
| HUTCHMED (China) | 2.59B |
| Bausch Health Companies | 2.07B |
| Perrigo Company | 1.89B |
| Dynavax Technologies | 1.76B |
| ANI Pharmaceuticals | 1.71B |
| Alvotech | 1.70B |
| BioCryst Pharmaceuticals | 1.65B |